Warnings that this antibiotic could cause serious swings in blood pressure were actually added in 2002, so we have to wonder how closely doctors were monitoring the patients involved in the more recent deaths from Tequin.
Bristol-Myers Squibb is warning against the use of the antibiotic drug Tequin in diabetic patients after reports of several fatalities, the U.S. Food and Drug Administration said on Thursday.
The company is adding a contraindication warning for diabetics to the drug’s label as well as strengthening its warning that Tequin can cause both low and high blood sugar levels in patients, the FDA said.
Shares were down 12 cents for the company. See full story.
Comments for this article are closed.